Other Assets, Noncurrent in USD of NovoCure Ltd from Q4 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
NovoCure Ltd quarterly Other Assets, Noncurrent history and change rate from Q4 2014 to Q3 2025.
  • NovoCure Ltd Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $12,413,000.000, a 1.55% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

NovoCure Ltd Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $12,413,000 +$189,000 +1.5% 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 $15,563,000 +$3,501,000 +29% 30 Jun 2025 10-Q 24 Jul 2025
Q1 2025 $14,484,000 -$415,000 -2.8% 31 Mar 2025 10-Q 24 Apr 2025
Q4 2024 $14,618,000 +$596,000 +4.2% 31 Dec 2024 10-Q 30 Oct 2025
Q3 2024 $12,224,000 -$192,000 -1.5% 30 Sep 2024 10-Q 30 Oct 2024
Q2 2024 $12,062,000 -$2,510,000 -17.2% 30 Jun 2024 10-Q 25 Jul 2024
Q1 2024 $14,899,000 +$3,752,000 +33.7% 31 Mar 2024 10-Q 02 May 2024
Q4 2023 $14,022,000 +$2,861,000 +25.6% 31 Dec 2023 10-K 27 Feb 2025
Q3 2023 $12,416,000 +$1,709,000 +16% 30 Sep 2023 10-Q 26 Oct 2023
Q2 2023 $14,572,000 +$3,674,000 +33.7% 30 Jun 2023 10-Q 27 Jul 2023
Q1 2023 $11,147,000 -$680,000 -5.8% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $11,161,000 -$925,000 -7.7% 31 Dec 2022 10-K 22 Feb 2024
Q3 2022 $10,707,000 -$28,000 -0.26% 30 Sep 2022 10-Q 27 Oct 2022
Q2 2022 $10,898,000 +$268,000 +2.5% 30 Jun 2022 10-Q 28 Jul 2022
Q1 2022 $11,827,000 +$1,039,000 +9.6% 31 Mar 2022 10-Q 28 Apr 2022
Q4 2021 $12,086,000 +$1,178,000 +10.8% 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 $10,735,000 -$304,000 -2.8% 30 Sep 2021 10-Q 28 Oct 2021
Q2 2021 $10,630,000 +$5,770,000 +1.2% 30 Jun 2021 10-Q 29 Jul 2021
Q1 2021 $10,788,000 +$5,964,000 +1.2% 31 Mar 2021 10-Q 29 Apr 2021
Q4 2020 $10,908,000 +$6,004,000 +1.2% 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 $11,039,000 +$5,322,000 +93.1% 30 Sep 2020 10-Q 29 Oct 2020
Q2 2020 $4,860,000 -$822,000 -14.5% 30 Jun 2020 10-Q/A 02 Oct 2020
Q1 2020 $4,824,000 -$151,000 -3% 31 Mar 2020 10-Q/A 02 Oct 2020
Q4 2019 $4,904,000 +$1,846,000 +60.4% 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $5,717,000 +$3,008,000 +1.1% 30 Sep 2019 10-Q 31 Oct 2019
Q2 2019 $5,682,000 +$2,805,000 +97.5% 30 Jun 2019 10-Q 25 Jul 2019
Q1 2019 $4,975,000 +$2,373,000 +91.2% 31 Mar 2019 10-Q 02 May 2019
Q4 2018 $3,058,000 +$1,072,000 +54% 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 $2,709,000 +$731,000 +37% 30 Sep 2018 10-Q 25 Oct 2018
Q2 2018 $2,877,000 +$1,111,000 +62.9% 30 Jun 2018 10-Q 26 Jul 2018
Q1 2018 $2,602,000 +$846,000 +48.2% 31 Mar 2018 10-Q 26 Apr 2018
Q4 2017 $1,986,000 +$486,000 +32.4% 31 Dec 2017 10-K 28 Feb 2019
Q3 2017 $1,978,000 +$332,000 +20.2% 30 Sep 2017 10-Q 26 Oct 2017
Q2 2017 $1,766,000 +$690,000 +64.1% 30 Jun 2017 10-Q 27 Jul 2017
Q1 2017 $1,756,000 +$764,000 +77% 31 Mar 2017 10-Q 27 Apr 2017
Q4 2016 $1,500,000 +$728,000 +94.3% 31 Dec 2016 10-K 22 Feb 2018
Q3 2016 $1,646,000 -$59,000 -3.5% 30 Sep 2016 10-Q 02 Nov 2016
Q2 2016 $1,076,000 30 Jun 2016 10-Q 28 Jul 2016
Q1 2016 $992,000 31 Mar 2016 10-Q 10 May 2016
Q4 2015 $772,000 +$545,000 +2.4% 31 Dec 2015 10-K 23 Feb 2017
Q3 2015 $1,705,000 30 Sep 2015 10-Q 27 Oct 2015
Q4 2014 $227,000 31 Dec 2014 10-K 01 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.